Home
About Us
Who we are
Founders and Chairs
Individual Members
Emeritus Members
Corporate and Research Members
Cambridge Angels Team
Infographic
Entrepreneurs
Why Cambridge Angels?
Is Angel Investing right for you?
Investment Criteria
Application Process
Apply
Angels
Membership Information
Member portal
Angel Interviews
Portfolio
Current Portfolio
Exits
Cambridge Angels Founded Companies
Portfolio facts
Portfolio Interviews
Apply to Cambridge Angels
News
Portfolio News
Ecosystem News

Welcome to the Cambridge Angels

Home
About Us
Who we are
Founders and Chairs
Individual Members
Emeritus Members
Corporate and Research Members
Cambridge Angels Team
Infographic
Entrepreneurs
Why Cambridge Angels?
Is Angel Investing right for you?
Investment Criteria
Application Process
Apply
Angels
Membership Information
Member portal
Angel Interviews
Portfolio
Current Portfolio
Exits
Cambridge Angels Founded Companies
Portfolio facts
Portfolio Interviews
Apply to Cambridge Angels
News
Portfolio News
Ecosystem News
Cambridge Cognition spin-out targets schizophrenia and post-operative cognitive dysfunction
1 July 2021
Cambridge Angels
Cambridge Cognition spin-out targets schizophrenia and post-operative cognitive dysfunction
Cambridge Angels
1 July 2021

Cambridge Cognition spin-out targets schizophrenia and post-operative cognitive dysfunction

Cambridge Angels
1 July 2021

Source:https://businesscloud.co.uk/new-chairman-at-biotech-phico/

Newer PostPervasID CEO & founder receives silver medal from the Royal Academy of Engineering
Older PostNew chairman at BioTech Phico
LI-In-Bug_small.png
Back to Top
Privacy
info@cambridgeangels.net